[go: up one dir, main page]

FI100107B - Menetelmä hyytymistä tehostavan tekijä VIII -fragmenttien yhdistelmän valmistamiseksi - Google Patents

Menetelmä hyytymistä tehostavan tekijä VIII -fragmenttien yhdistelmän valmistamiseksi Download PDF

Info

Publication number
FI100107B
FI100107B FI880852A FI880852A FI100107B FI 100107 B FI100107 B FI 100107B FI 880852 A FI880852 A FI 880852A FI 880852 A FI880852 A FI 880852A FI 100107 B FI100107 B FI 100107B
Authority
FI
Finland
Prior art keywords
fviii
molecular weight
units
fragments
incubation
Prior art date
Application number
FI880852A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI880852A (fi
FI880852A0 (fi
Inventor
Ole Nordfang
Mirella Ezban Rasmussen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK1987/000080 external-priority patent/WO1988000210A1/en
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI880852A publication Critical patent/FI880852A/fi
Publication of FI880852A0 publication Critical patent/FI880852A0/fi
Application granted granted Critical
Publication of FI100107B publication Critical patent/FI100107B/fi

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI880852A 1986-06-24 1988-02-23 Menetelmä hyytymistä tehostavan tekijä VIII -fragmenttien yhdistelmän valmistamiseksi FI100107B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK295786 1986-06-24
DK295786A DK295786A (da) 1986-06-24 1986-06-24 Fremgangsmaade til fremstilling af et koagulationsaktivt kompleks af faktor viii fragmenter
DK8700080 1987-06-24
PCT/DK1987/000080 WO1988000210A1 (en) 1986-06-24 1987-06-24 A process for producing a coagulation active complex of factor viii fragments

Publications (3)

Publication Number Publication Date
FI880852A FI880852A (fi) 1988-02-23
FI880852A0 FI880852A0 (fi) 1988-02-23
FI100107B true FI100107B (fi) 1997-09-30

Family

ID=8117562

Family Applications (1)

Application Number Title Priority Date Filing Date
FI880852A FI100107B (fi) 1986-06-24 1988-02-23 Menetelmä hyytymistä tehostavan tekijä VIII -fragmenttien yhdistelmän valmistamiseksi

Country Status (4)

Country Link
JP (1) JP2677546B2 (ja)
AT (1) ATE100825T1 (ja)
DK (2) DK295786A (ja)
FI (1) FI100107B (ja)

Also Published As

Publication number Publication date
FI880852A (fi) 1988-02-23
DK295786A (da) 1987-12-25
DK163833C (da) 1992-09-21
DK92188A (da) 1988-02-23
DK295786D0 (da) 1986-06-24
DK163833B (da) 1992-04-06
JP2677546B2 (ja) 1997-11-17
ATE100825T1 (de) 1994-02-15
FI880852A0 (fi) 1988-02-23
DK92188D0 (da) 1988-02-23
JPH09117281A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
US5543502A (en) Process for producing a coagulation active complex of factor VIII fragments
Heeb et al. Protein S binds to and inhibits factor Xa.
Rosing et al. Characterization of two forms of human factor Va with different cofactor activities.
Lovely et al. Fibrinogen γ′ chain binds thrombin exosite II
Nakamura et al. Fragmentation of an endogenous inhibitor upon complex formation with high-and low-calcium requiring forms of calcium-activated neutral proteases
Atoda et al. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization
KR100457984B1 (ko) 인자 vii 및 활성화된 인자 vii의 정제방법
EP0272304B1 (en) A process for producing a coagulation active complex of factor viii fragments
DEGUCHI et al. Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex
CA2154080C (en) Novel anticoagulant cofactor activity
CA2253246A1 (en) Purified multimerase
Yoshida et al. Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis.
US6034222A (en) Method for the separation of recombinant pro-factor IX from recombinant factor IX
FI100107B (fi) Menetelmä hyytymistä tehostavan tekijä VIII -fragmenttien yhdistelmän valmistamiseksi
Atkins et al. The association of human coagulation factors VIII, IXa and X with phospholipid vesicles involves both electrostatic and hydrophobic interactions
Arvieux et al. Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein
Thorelli et al. Cleavage requirements of factor V in tissue-factor induced thrombin generation
Kemball‐Cook et al. The behaviour of different factor VIII concentrates in a chromogenic factor X‐activating system
Sugo et al. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations
Knör et al. Efficient factor VIII affinity purification using a small synthetic ligand
Matsuda et al. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A
De Caterina et al. Cellular effects of thrombin: pharmacology of the receptor (s) in various cell types and possible development of receptor antagonists
JP2593500C (ja)
Marlar et al. Formation and properties of a thrombin generated factor IX inhibitor
Mannhalter Biochemical and functional properties of factor XI and prekallikrein

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NOVO NORDISK A/S